Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.2.2
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of RSUs granted and outstanding
    Unvested
Restricted		     Weighted
Average
Grant
Date		  
    Stock     FV Price  
Unvested as of January 1, 2022     -     $
-
  
Granted     12,000       4.05  
Vested     5,000       4.05  
Unvested as of September 30, 2022     7,000       4.05  
Total unrecognized expense remaining   $ 28,350          
Weighted-average years expected to be recognized over     1.25      
-
  

 
Schedule of option activity
          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Years)     Value  
Outstanding, January 1, 2022     2,741,000       4.77       9.4       70,500  
Granted     518,121       1.36      
-
      
-
  
Exercised    
-
      
-
      
-
      
-
  
Expired    
-
      
-
      
-
      
-
  
Forfeited    
-
      
-
      
-
      
-
  
Outstanding, September 30, 2022     3,259,121       4.23       8.8     $
-
  
                                 
Exercisable, September 30, 2022     1,660,057       4.16       8.7     $
-
  

 
Schedule of RSUs granted and outstanding
Risk-free interest rate     2.88 %
Expected term in years     5.00-5.77  
Expected volatility     91.00 %
Expected dividends     0 %

 
Schedule of outstanding and exercisable stock options
Stock Options Outstanding     Stock Options Exercisable  
            Weighted        
            Average        
Exercise     Number of     Remaining     Number of  
Price     Shares     Life in Years     Shares  
$ 2.49       50,000       8.2       50,000  
$ 4.43       1,580,000       8.4       983,111  
$ 7.56       436,000       8.8       127,167  
$ 3.95       675,000       9.2       301,042  
$ 1.36       518,121       9.6       198,737  
          3,259,121       8.7       1,660,057